Founders Capital Management (Connecticut)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.65M | Buy |
|
|||||
|
2025
Q2 | $4.34M | Buy |
|
|||||
|
2025
Q1 | $4.91M | Sell |
|
|||||
|
2024
Q4 | $5.68M | Buy |
|
|||||
|
2024
Q3 | $8.13M | Sell |
|
|||||
|
2024
Q2 | $8.18M | Sell |
|
|||||
|
2024
Q1 | $7.54M | Hold |
|
|||||
|
2023
Q4 | $6.88M | Sell |
|
|||||
|
2023
Q3 | $6.53M | Sell |
|
|||||
|
2023
Q2 | $5.77M | Sell |
|
|||||
|
2023
Q1 | $6.71M | Sell |
|
|||||
|
2022
Q4 | $5.98M | Sell |
|
|||||
|
2022
Q3 | $5.86M | Sell |
|
|||||
|
2022
Q2 | $5.09M | Buy |
|
|||||
|
2022
Q1 | $6M | Buy |
|
|||||
|
2021
Q4 | $5.37M | Sell |
|
|||||
|
2021
Q3 | $5.33M | Sell |
|
|||||
|
2021
Q2 | $4.98M | Buy |
|
|||||
|
2021
Q1 | $1.85M | Buy |
|
|||||
|
2020
Q4 | $279K | Hold |
|
|||||
|
2020
Q3 | $323K | Hold |
|
|||||
|
2020
Q2 | $360K | Hold |
|
|||||
|
2020
Q1 | $282K | Hold |
|
|||||
|
2019
Q4 | $217K | Hold |
|
|||||
|
2019
Q3 | $163K | Hold |
|
|||||
|
2019
Q2 | $181K | Hold |
|
|||||
|
2019
Q1 | $237K | Hold |
|
|||||
|
2018
Q4 | $216K | Hold |
|
|||||
|
2018
Q3 | $226K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $217K | Hold |
|
|||||
|
2017
Q3 | $258K | Sell |
|
|||||
|
2017
Q2 | $333K | Hold |
|
|||||
|
2017
Q1 | $262K | Hold |
|
|||||
|
2016
Q4 | $249K | Hold |
|
|||||
|
2016
Q3 | $272K | Hold |
|
|||||
|
2016
Q2 | $236K | Hold |
|
|||||
|
2016
Q1 | $244K | Hold |
|
|||||
|
2015
Q4 | $368K | Hold |
|
|||||
|
2015
Q3 | $315K | Hold |
|
|||||
|
2015
Q2 | $345K | Hold |
|
|||||
|
2015
Q1 | $306K | Hold |
|
|||||
|
2014
Q4 | $278K | Hold |
|
|||||
|
2014
Q3 | $244K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $203K | Buy |
|